Michiel Tent summarises 6 abstracts from the MS Virtual 2020 and its Encore Event:
- EDSS and age are risk factors for severe COVID-19 in MS patients
Louapre C. MSVIRTUAL2020, Abstract SS02.06. - Brain alterations at onset of first demyelinating event
Collorone S. MSVIRTUAL2020, Abstract LB01.04. - Amantadine, modafinil, and methylphenidate for MS-related fatigue
Nourbakhsh B, et al. MSVIRTUAL2020, Abstract PS13.03. - Masitinib possible new treatment of progressive MS
Vermersch P, et al. MSVIRTUAL2020, Abstract FC04.01. - No new safety signals in ofatumumab open-label data
Cross AH, et al. MSVIRTUAL2020, Abstract P0234. - The MS prodrome
Tremlett H. MSVIRTUAL2020, Abstract PL01.01.
- EDSS and age are risk factors for severe COVID-19 in MS patients
© 2023 The Author(s). Published by Medicom Medical Publishers.
User license: Creative Commons Attribution – NonCommercial (CC BY-NC 4.0)
Posted on
Previous Article
« Experts recommend three dosing protocols for medical cannabis when treating chronic pain Next Article
Numerous drugs can spawn a broad range of arrhythmias »
« Experts recommend three dosing protocols for medical cannabis when treating chronic pain Next Article
Numerous drugs can spawn a broad range of arrhythmias »
Table of Contents: MS Virtual 2020
Featured articles
COVID-19 and MS
Biomarkers
Treatment Strategies and Results
Management of progressive MS with approved DMT
Novel Treatment Directions
Neuromyelitis Optica Spectrum Disorders
Miscellaneous Topics
Related Articles
December 9, 2021
WNT9B-gene variant associated with doubled relapse risk in MS
December 9, 2021
Top score poster: Meta-analysis on the effect of DMTs

December 9, 2021
Anti-CD20 antibodies associated with worse COVID-19 outcomes
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy